NEUCA S.A. (WSE:NEU)

Market Cap	3.26B +7.0%
Revenue (ttm)	13.64B +8.2%
Net Income	155.58M +0.9%
EPS	34.05 +0.1%
Shares Out	4.51M
PE Ratio	21.23
Forward PE	17.01
Dividend	17.80 (2.50%)
Ex-Dividend Date	Jun 29, 2026

Volume	1,626
Average Volume	1,915
Open	714.00
Previous Close	712.00
Day's Range	713.00 - 734.00
52-Week Range	645.00 - 857.00
Beta	0.45
RSI	56.46
Earnings Date	May 21, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.